EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+7.08%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$303M
AUM Growth
+$303M
(+16%)
Cap. Flow
+$16.6M
Cap. Flow
% of AUM
5.48%
Top 10 Holdings %
Top 10 Hldgs %
78.52%
Holding
40
New
10
Increased
5
Reduced
8
Closed
7
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$19.8M |
| 2 |
Ascendis Pharma
ASND
|
$15.3M |
| 3 |
Aclaris Therapeutics
ACRS
|
$11.2M |
| 4 |
Editas Medicine
EDIT
|
$10.2M |
| 5 |
Xencor
XNCR
|
$9.87M |
Top Sells
| 1 |
DERM
Dermira, Inc.
DERM
|
$14.5M |
| 2 |
Cytokinetics
CYTK
|
$9.62M |
| 3 |
KA
Kineta, Inc. Common Stock
KA
|
$9.39M |
| 4 |
AKAO
Achaogen, Inc.
AKAO
|
$8.05M |
| 5 |
Agios Pharmaceuticals
AGIO
|
$7.37M |
Sector Composition
| 1 | Healthcare | 90% |
| 2 | Industrials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TMBR
26
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
| $502K | 0.16% |
+1,342,000
| New | +$502K |
|
27
Bristol-Myers Squibb
BMY
$96.7B
| $500K | 0.16% |
+8,560
| New | +$500K |
|
|
CASC
28
DELISTED
Cascadian Therapeutics, Inc.
CASC
| – | – |
0
| – | – |
|
|
OMED
29
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| – | – |
-265,784
| Closed | -$3.04M |
|
30
Exact Sciences
EXAS
$9.33B
| – | – |
0
| – | – |
|
31
Fate Therapeutics
FATE
$115M
| – | – |
-590,527
| Closed | -$1.84M |
|
32
Gilead Sciences
GILD
$140B
| – | – |
0
| – | – |
|
33
Intellia Therapeutics
NTLA
$1.26B
| – | – |
-200,858
| Closed | -$3.42M |
|
|
ONC
34
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| – | – |
-163,470
| Closed | -$5.04M |
|
|
KA
35
DELISTED
Kineta, Inc. Common Stock
KA
| – | – |
-602,315
| Closed | -$9.39M |
|
|
AGN
36
DELISTED
Allergan plc
AGN
| – | – |
0
| – | – |
|
|
ONCE
37
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| – | – |
-68,600
| Closed | -$4.12M |
|
|
AKAO
38
DELISTED
Achaogen, Inc.
AKAO
| – | – |
-1,679,707
| Closed | -$8.05M |
|